Evidence map›Paper›PMID 37059887›Full record

ArticleArchives of virology2023

Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda.

Phionah Tushabe, Josephine Bwogi, James Peter Eliku, Francis Aine, Molly Birungi, Joseph Gaizi, Lucy Nakabazzi, Theopista Kabaliisa, Irene Turyahabwe, Prossy Namuwulya and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Archives of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Phionah TushabeExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda. ptushabe@uvri.go.ug.ORCID http://orcid.org/0000-0002-0729-5505
Josephine BwogiExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
James Peter ElikuExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Francis AineExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Molly BirungiExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Joseph GaiziExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Lucy NakabazziExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Theopista KabaliisaExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Irene TuryahabweExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Prossy NamuwulyaExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Mary Bridget NantezaExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Henry BukenyaExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Christopher KanyesigyeNational Water and Sewerage Corporation, Kampala, Uganda.
Edson KatushabeWorld Health Organization, Uganda Country Office, Kampala, Uganda.
Immaculate AmpeireMinistry of Health Uganda, Kampala, Uganda.
Annet KisakyeWorld Health Organization, Uganda Country Office, Kampala, Uganda.
Barnabas BakamutumahoExpanded Programme on Immunization Laboratory, Uganda Virus Research Institute, Entebbe, Uganda.
Charles R ByabamazimaWHO Inter-Country Support Team Office for Eastern and Southern Africa (IST/ESA), Harare, Zimbabwe.
Uganda Virus Research Institute · UGWorld Health Organization - Uganda · UGMinistry of Health · UGNational Water and Sewerage Corporation · UGWorld Health Organization - Zimbabwe · ZW

Funding

Medical Research Council MC_UU_00033/1World Health Organization 001
6 · The paper itself

Abstract

The success of the global polio eradication initiative is threatened by the genetic instability of the oral polio vaccine, which can result in the emergence of pathogenic vaccine-derived polioviruses following prolonged replication in the guts of individuals with primary immune deficiencies or in communities with low vaccination coverage. Through environmental surveillance, circulating vaccine-derived poliovirus type 2 was detected in Uganda in the absence of detection by acute flaccid paralysis (AFP) surveillance. This underscores the sensitivity of environmental surveillance and emphasizes its usefulness in supplementing AFP surveillance for poliovirus infections in the race towards global polio eradication.

Indexed as

PoliomyelitisPoliovirusPoliovirus Vaccine, Oralalpha-FetoproteinsCentral Nervous System Viral DiseasesEnvironmental MonitoringHumansMyelitisNeuromuscular DiseasesParalysisPopulation SurveillanceUgandaalpha-FetoproteinsPoliovirus Vaccine, Oral

Identifiers

PMID37059887
PMCPMC10104764
OpenAlexW4365810888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.